Alaunos Therapeutics Inc.

NASDAQ: TCRT · Real-Time Price · USD
2.27
-0.13 (-5.42%)
At close: Aug 15, 2025, 3:59 PM
2.20
-2.87%
After-hours: Aug 15, 2025, 07:31 PM EDT

Alaunos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.09M 6.06M 39.06M 76.05M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 542K 673K
Receivables
5K 1K 4K 1.11M
Inventory
n/a n/a 13.94M n/a
Other Current Assets
1.66M 2.2M 799K 1.67M
Total Current Assets
2.75M 8.26M 53.8M 78.83M
Property-Plant & Equipment
n/a 2K 10.6M 15.36M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a 2K 11.14M 16.03M
Total Assets
2.75M 8.26M 64.94M 94.86M
Account Payables
516K 616K 1.39M 1.37M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 17.32M 8.6M
Other Current Liabilities
n/a 1.3M 3.74M 3.65M
Total Current Liabilities
692K 1.96M 24.17M 16.04M
Long-Term Debt
n/a n/a n/a 16.25M
Other Long-Term Liabilities
n/a n/a 28K -1K
Total Long-Term Liabilities
n/a n/a 2.22M 20.77M
Total Liabilities
692K 1.96M 26.38M 36.81M
Total Debt
n/a n/a 19.51M 29.36M
Common Stock
2K 16K 240K 216K
Retained Earnings
-920.45M -915.77M -880.63M -842.85M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
2.06M 6.31M 38.55M 58.06M
Total Investments
n/a n/a n/a n/a